Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2017

Heat shock-induced phosphorylation of TAR DNA-binding protein
43 (TDP-43) by MAPK/ERK kinase regulates TDP-43 function
Wen Li
Saint Louis University

Ashley N. Reeb
Saint Louis University

Binyan Lin
Saint Louis University

Praveen Subramanian
Saint Louis University

Erin E. Fey
Saint Louis University

See next page for additional authors

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Li, Wen; Reeb, Ashley N.; Lin, Binyan; Subramanian, Praveen; Fey, Erin E.; Knoverek, Catherine R.; French,
Rachel L.; Bigio, Eileen H.; and Ayala, Yuna M., ,"Heat shock-induced phosphorylation of TAR DNA-binding
protein 43 (TDP-43) by MAPK/ERK kinase regulates TDP-43 function." The Journal of Biological
Chemistry. 292,12. 5089-5100. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/5866

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
Wen Li, Ashley N. Reeb, Binyan Lin, Praveen Subramanian, Erin E. Fey, Catherine R. Knoverek, Rachel L.
French, Eileen H. Bigio, and Yuna M. Ayala

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/5866

crossmark
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 292, NO. 12, pp. 5089 –5100, March 24, 2017
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.

Heat Shock-induced Phosphorylation of TAR DNA-binding
Protein 43 (TDP-43) by MAPK/ERK Kinase Regulates TDP-43
Function*□
S

Received for publication, August 16, 2016, and in revised form, February 3, 2017 Published, JBC Papers in Press, February 6, 2017, DOI 10.1074/jbc.M116.753913

Wen Li‡, Ashley N. Reeb‡, Binyan Lin‡, Praveen Subramanian‡1, Erin E. Fey‡2, Catherine R. Knoverek‡3,
Rachel L. French‡, Eileen H. Bigio§, and Yuna M. Ayala‡4
From the ‡Edward Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine,
St. Louis, Missouri 63104 and the §Department of Pathology, Northwestern University Feinberg School of Medicine,
Chicago, Illinois 60611
Edited by Paul E. Fraser

* This work was supported in part by the National Institutes of Health, NINDS
Grant K01 NS082391 and St. Louis University Presidential Research Fund
Grant 230175. The authors declare that they have no conflicts of interest
with the contents of this article. The content is solely the responsibility of
the authors and does not necessarily represent the official views of the
National Institutes of Health.
□
S
This article contains supplemental Figs. S1–S8 and Table S1.
1
Present address: A.T. Still University-Kirksville College of Osteopathic Medicine, Kirksville, MO 63501.
2
Present address: Dept. of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232.
3
Present address: Dept. of Computational and Molecular Biophysics, Washington University, St. Louis, MO 63110.
4
To whom correspondence should be addressed. Tel.: 314-977-9247; Fax:
314-977-9206; E-mail: yayala@slu.edu.

MARCH 24, 2017 • VOLUME 292 • NUMBER 12

uncover previously unexplored roles of TDP-43 in cell
metabolism.

In recent years the role of RNA-binding proteins in neurodegenerative disorders, particularly amytrophic lateral sclerosis
(ALS) and frontotemporal lobar degeneration (FTLD)5 has
become the focus of intense research. The TAR DNA-binding
protein (TDP-43) forms cytoplasmic aggregates in almost all
ALS and ⬃50% of FTLD cases (1, 2). TDP-43 pathology is
observed in other neurological disorders including Alzheimer’s
disease (3, 4). The direct role TDP-43 plays in disease is underscored by ⬎40 ALS/FTLD patient-derived autosomal dominant missense mutations in the TDP-43 gene (TARDBP) (5).
TDP-43 inclusions coincide with a dramatic reduction of the
normal nuclear TDP-43 detection (2), implying a loss of
function upon aggregate accumulation. The link between
neurodegeneration and TDP-43 function has not been
clearly established and the contribution of TDP-43 aggregation to pathogenesis is poorly understood.
TDP-43 is a highly conserved heterogeneous nuclear ribonucleoprotein (hnRNP) with two canonical RNA recognition
motifs (RRMs) of which RRM1 is necessary and sufficient to
bind RNA. A low complexity sequence, or prion-like domain at
the C terminus mediates protein interactions required for RNA
processing (6, 7) and is the main driver of protein aggregation
(8). Although TDP-43 shuttles between nucleus and cytoplasm,
it is predominantly nuclear (9). In the nucleus, TDP-43 shows a
diffuse pattern and recruitment to Cajal bodies and gems (10).
Under specific cellular stress conditions, such as oxidative
stress, TDP-43 localizes to cytoplasmic stress granules (11),
which may contribute to pathological aggregate formation (12).
TDP-43 is essential for development and survival in animal
models and cultured cells (13–17). In human cells and mouse
brain, TDP-43 binds thousands of transcripts with a strong
preference for GU-rich sequences and regulates ⬎600 protein5

The abbreviations used are: FTLD, frontotemporal lobar degeneration; RRM,
RNA recognition motif; hnRNP, heterogeneous nuclear ribonucleoprotein;
TDP-43, TAR DNA-binding protein; HSR, heat shock response; DFC, dense
fibrillar component; SG, stress granule; TIAR, T-cell-restricted intracellular
antigen-related protein; UPS, ubiquitin proteasome system; CFTR, cystic
fibrosis transmembrane conductance regulator; HSF, heat shock factor.
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TAR DNA-binding protein (TDP-43) is a highly conserved
and essential DNA- and RNA-binding protein that controls
gene expression through RNA processing, in particular, regulation of splicing. Intracellular aggregation of TDP-43 is a hallmark of amyotrophic lateral sclerosis and ubiquitin-positive
frontotemporal lobar degeneration. This TDP-43 pathology is
also present in other types of neurodegeneration including Alzheimer’s disease. We report here that TDP-43 is a substrate of
MEK, a central kinase in the MAPK/ERK signaling pathway.
TDP-43 dual phosphorylation by MEK, at threonine 153 and
tyrosine 155 (p-T153/Y155), was dramatically increased by the
heat shock response (HSR) in human cells. HSR promotes cell
survival under proteotoxic conditions by maintaining protein
homeostasis and preventing protein misfolding. MEK is activated by HSR and contributes to the regulation of proteome
stability. Phosphorylated TDP-43 was not associated with
TDP-43 aggregation, and p-T153/Y155 remained soluble
under conditions that promote protein misfolding. We found
that active MEK significantly alters TDP-43-regulated splicing and that phosphomimetic substitutions at these two residues reduce binding to GU-rich RNA. Cellular imaging using
a phospho-specific p-T153/Y155 antibody showed that phosphorylated TDP-43 was specifically recruited to the nucleoli,
suggesting that p-T153/Y155 regulates a previously unappreciated function of TDP-43 in the processing of nucleolarassociated RNA. These findings highlight a new mechanism
that regulates TDP-43 function and homeostasis through
phosphorylation and, therefore, may contribute to the development of strategies to prevent TDP-43 aggregation and to

Novel TDP-43 Phosphorylation Is Heat Shock-induced via MEK

Results
The Heat Shock Response Controls TDP-43 Phosphorylation
in RRM1—TDP-43 phosphorylation at threonine 153 and tyrosine 155, located in RRM1 (Fig. 1, A and B), was identified by
large scale phosphoproteome mass spectrometry analysis of
human HeLa cells (23). These modifications were determined
under non-pathological conditions. To characterize these previously unexplored phosphorylation sites, we developed a novel
phospho-specific polyclonal antibody, p-T153/Y155-TDP-43,
to recognize dual TDP-43 phosphorylation at Thr-153/Tyr155. The basal levels of the protein recognized by p-T153/
Y155-TDP-43 were almost undetectable by immunoblotting in
different human cell lines including SH-SY5Y human neuroblastoma cells (Fig. 1, C and D, supplemental Fig. S1). However,
we found that heat shock dramatically up-regulated the
p-T153/Y155-TDP-43-associated signal. No significant increase
was observed under conditions of oxidative stress, DNA damage stress, or transcription inhibition (Fig. 1C). Similar results
were obtained with heat shock stressed human HEK-293 (supplemental Fig. S1) and HeLa cells (Fig. 2A). The levels of
p-T153/Y155-TDP-43-associated signal were undetectable in
control cell lysates with ⬎150 g of total protein (Fig. 1D, supplemental Fig. S1). In contrast, this signal was observed in heat
shock-treated cell lysate starting from ⬃20 g of total protein
(Fig. 1D, supplemental Fig. S1). We confirmed antibody specificity for TDP-43 phosphorylation at Thr-153/Tyr-155 through
different analyses. The signal associated with p-T153/Y155TDP-43 following heat shock was significantly reduced upon
TDP-43 knockdown (Fig. 2A). Incubation of the antibody with
a TDP-43 peptide (amino acids 148 –161) phosphorylated at
Thr-153 and Tyr-155 resulted in a loss of the p-T153/Y155TDP-43-associated signal, whereas the non-phosphorylated
control peptide had no effect (Fig. 2B). Furthermore, phosphatase treatment of lysate from heat-shocked cells decreased the
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levels of the p-T153/Y155-TDP-43-associated signal compared
with control (Fig. 2C). To further characterize the specificity of
our new antibody for dual phosphorylation at Thr-153 and Tyr155, we determined p-T153/Y155-TDP-43 activity toward single phosphorylation at Thr-153 or Tyr-155. Immunoblotting
competition assays were carried out using peptides phosphorylated at single amino acid residues Thr-153 or Tyr-155 (supplemental Fig. S2, A and B). The peptide phosphorylated at
Thr-153 (Thr(P)-153) was unable to block recognition of the
p-T153/Y155-TDP-43-associated band. Similar high concentrations of the Tyr-155 phosphorylated peptide (Tyr(P)-155,
0.1 g/ml) showed partial inhibition of p-T153/Y155-TDP-43
activity. However, blocking the antibody with decreasing concentrations of the Tyr(P)-155 peptide showed no significant
competing activity as compared with equal concentrations of
the p-T153/Y155 dual phosphorylated peptide (supplemental
Fig. S2B). Furthermore, we analyzed whether the heat shockassociated signal could be detected by an antibody generated to
recognize single phosphorylation at Tyr-155 (p-Y155-TDP43). This antibody showed no detection of the p-T153/Y155TDP-43-associated signal under control or heat shock conditions (supplemental Fig. S2C). Collectively, these results
strongly support the specificity of the newly developed p-T153/
Y155-TDP-43 antibody for dual TDP-43 phosphorylation at
Thr-153 and Tyr-155, and show the regulation of TDP-43 posttranslational modification by the HSR.
To confirm our results and to determine whether phosphorylation at Thr-153/Tyr-155 modifies cellular localization of
TDP-43, we characterized the p-T153/Y155-TDP-43 antibody
by indirect immunofluorescence analysis. In non-treated cells,
the p-T153/Y155-TDP-43-associated signal localized in the
nucleolar compartment as dense coil-like structures (Fig. 3).
This was observed in different human cell lines, including
HeLa, SH-SY5Y (Fig. 3, A and B), U2-OS, and HEK-293 cells
(not shown). We confirmed antibody specificity for TDP-43
phosphorylation at Thr-153/Tyr-155 in our immunofluorescence assays by RNAi-mediated knockdown of TDP-43 and
competition assays with the Thr-153 and Tyr-155 phosphorylated peptide (amino acids 148 –161) as above. Detection of the
nucleolar signal was blocked in the presence of the phosphorylated peptide, whereas incubation of the antibody with the nonphosphorylated form of the peptide had no effect (supplemental Fig. S3A). Furthermore, knockdown of TDP-43 via shRNA
reduced levels of the nucleolar signal compared with control
treated cells (supplemental Fig. S3B). These results suggest that
p-T153/Y155 is associated with nucleolar localization of
TDP-43 under normal conditions. This is in agreement with
previous mass spectrometry detection of TDP-43 in the nucleolar domain of HeLa cells (24). The levels of total TDP-43
recruited to nucleoli appear to be considerably lower compared
with the rest of the nucleus, based on the detection of phosphoindependent TDP-43 (Fig. 3A). Confocal microscopy analyses
of HeLa and SH-SY5Y cells suggest that phosphorylated
TDP-43 is part of the dense fibrillar component (DFC) of nucleoli as we observed significant colocalization with fibrillarin, a
well established DFC marker (Fig. 3B). Localization of p-T153/
Y155 in the nucleolus was maintained following heat shock.
Quantification of p-T153/Y155 levels throughout the cell
VOLUME 292 • NUMBER 12 • MARCH 24, 2017
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coding genes. TDP-43 controls these genes predominantly
through splicing regulation (18 –20). Although TDP-43 participates in different mechanisms of RNA processing and RNA
transport, the regulation of splicing is its best-characterized
function (20, 21). In addition, recent findings show that TDP-43
plays a more global role in gene regulation as an inhibitor of
cryptic exon inclusion (22).
Despite evidence that TDP-43 controls a large number of
genes and is dynamically distributed in cells, the cellular stimuli
and factors that regulate TDP-43 function through posttranslational modifications are still mostly unknown. We characterized new TDP-43 phosphorylation sites found in non-pathological settings and sought to determine the mechanisms that
control them. Our findings show that activation of the cellular
heat shock response (HSR) dramatically increases TDP-43
phosphorylation at Thr-153 and Tyr-155 through the MAPK/ERK
kinase MEK, in the absence of increased TDP-43 aggregation or
protein clearance. Increased Thr-153/Tyr-155 phosphorylation in
the presence of active MEK and phosphomimetic substitutions at
Thr-153/Tyr-155 show decreased splicing regulatory function.
Moreover, phosphomimetic substitutions at Thr-153/Tyr155 decrease RNA binding affinity, suggesting that phosphorylation at these sites modulates TDP-43 activity.

Novel TDP-43 Phosphorylation Is Heat Shock-induced via MEK
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FIGURE 1. Heat shock induces TDP-43 phosphorylation at Thr-153 and Tyr-155. A, schematic representation highlighting TDP-43 domains linked to protein
activity and structure: nuclear localization sequence (NLS) at the N terminus, RRM 1 and 2, and the low complexity sequence at the C terminus. Threonine 153
and tyrosine 155 (red) are highlighted in the RRM1 insert. B, ribbon and surface representation of TDP-43 RRM1–2 fragment (amino acids 102–269) bound to a
UG-rich RNA molecule (gray) based on an NMR structure of the complex (36). Thr-153 and Tyr-155 are highlighted in red. C, immunoblots of SH-SY5Y cells
exposed to heat shock, 43 °C for 30 min; treated with sodium arsenite, 0.5 mM for 1 h (NaAsn); H2O2, 100 M for 5 h; hydroxyurea, 4 mM for 4 h (HU); and
actinomycin D, 5 g/ml for 3 h (Act D). D, immunoblots of increasing cell lysate derived from control and heat shock-treated SH-SY5Y cells. An antibody
recognizing total, phospho-independent TDP-43 was used as control. Tubulin and GAPDH were used as loading control.

showed an increase in relative fluorescence after heat shock of
50 and 40% in HeLa and HEK-293 cells, respectively (Fig. 3C,
supplemental Fig. S4). Further experiments are required to
determine whether the increase in phosphorylation during
HSR primarily derives from changes in the nucleolar compartment, relative to the rest of the cell.
TDP-43 Phosphorylation Is Not Associated with Aggregation,
Stress Granules, or Protein Clearance—We analyzed TDP-43
aggregation following heat shock to determine whether
p-T153/Y155 was associated with changes in protein solubility,
and to compare p-T153/Y155 with the two previously determined TDP-43 phosphorylation sites Ser-403/404, Ser-409/
MARCH 24, 2017 • VOLUME 292 • NUMBER 12

410, which are tightly linked to aggregation and pathology (25,
26). Heat shock significantly induced misfolding and accumulation of total TDP-43 in the insoluble fraction following protein extraction from cellular lysate (CL) into RIPA (R) and urea
(U) soluble fractions. Immunoblot analysis showed a great
reduction of total TDP-43 in the RIPA soluble fraction and a
corresponding increase in the urea soluble sample after heat
shock (Fig. 4A). In contrast, p-T153/Y155 was present exclusively in the RIPA soluble fraction. Recovery from heat shock by
incubation at 37 °C reduced the levels of total TDP-43 in the
urea fraction, indicating clearance of misfolded TDP-43 and/or
chaperone-assisted refolding of the protein. At the same time,
JOURNAL OF BIOLOGICAL CHEMISTRY
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the levels of p-T153/Y155 greatly decreased during recovery.
These results are consistent with imaging analysis, which
showed no accumulation of p-T153/Y155 into visible aggregates following heat shock (Fig. 3C). Even though total TDP-43
accumulated in the urea fraction following heat shock, we did
not observe accumulation of total TDP-43 into cytoplasmic
aggregates (Fig. 3C), suggesting that TDP-43 present in the urea
fraction after heat shock represents misfolded species that may
precede formation of larger, visible aggregates.
To determine whether phosphorylation of Thr-153 and Tyr155 is associated with pathological inclusions in disease conditions, we analyzed p-T153/Y155 localization in FTLD cases. As
positive control for the presence of TDP-43 pathology, we used
an antibody recognizing phosphorylated Ser-409/410, which is
a well established marker of TDP-43 disease-associated inclu-
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sions (25). Immunohistochemical analysis of frontotemporal
dementia brain sections showed no significant accumulation of
p-T153/Y155 in aggregates (supplemental Fig. S5). These initial
observations suggest that, unlike previously identified phosphorylation events (i.e. Ser(P)-403/404 and Ser(P)-409/410),
p-T153/Y155 is not linked to the formation of aggregates in
FTLD. This is in agreement with our cell-based data suggesting
that p-T153/Y155 regulates TDP-43 function and localization
and that it is linked to soluble protein under conditions that
promote TDP-43 misfolding (Fig. 4A). However, at this time,
we cannot exclude the possibility that increased p-T153/Y155
levels, or specific patterns of detection may be observed in different types of TDP-43 proteinopathies.
TDP-43 recruitment to stress granules (SGs) has been
observed upon exposure to oxidative and proteotoxic stress
(11). To investigate whether phosphorylation mediates recruitment of TDP-43 to SGs upon heat shock, we analyzed the colocalization of p-T153/Y155 with the SG marker T-cell-restricted
intracellular antigen-related protein (TIAR). TIAR-positive
SGs formed in the cytoplasm following heat shock (Fig. 4C).
However, we did not observe recruitment of p-T153/Y155 or
VOLUME 292 • NUMBER 12 • MARCH 24, 2017
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FIGURE 2. Antibody p-T153/Y155-TDP-43 specifically detects heat shockmediated TDP-43 phosphorylation. A, immunoblots of HeLa cells treated
with TDP-43-specific and control siRNA to compare levels of p-T153/Y155TDP-43 following heat shock stress. Error bars, S.D. n ⫽ 4. B, detection of the
heat shock-associated signal in SH-SY5Y cell lysate with p-T153/Y155-TDP-43
antibody blocked with a TDP-43 peptide corresponding to the Thr-153/Tyr155 region (amino acids 148 –161) phosphorylated at Thr-153 and Tyr-155
(T153P/Y155P), or with the corresponding non-phosphorylated peptide, as
control. Two concentrations of peptides were used low (L) and high (H),
described under “Experimental Procedures.” C, p-T153/Y155-TDP-43 detection of control and -phosphatase-treated lysates from control and heat
shock-treated SH-SY5Y cells.

FIGURE 3. p-T153/Y155-TDP-43 detects nucleolar localization of TDP-43
in the dense coil-like structures. A, fluorescence imaging of non-treated
HeLa cells showing total TDP-43 and p-T153/Y155-TDP-43 localization. B,
p-T153/Y155 colocalization with the nucleolar marker fibrillarin in HeLa and
SH-SY5Y cells as seen by confocal microscopy. C, detection of p-T153/Y155 in
HeLa cells upon heat shock compared with control-treated cells. Bars, 10 m.

Novel TDP-43 Phosphorylation Is Heat Shock-induced via MEK

phospho-independent TDP-43 to SGs, in agreement with previous reports (27). In summary, our findings indicate that phosphorylation at Thr-153/Tyr-155 is not linked to aggregation or
stress granule recruitment of TDP-43. Instead, we find that in
conditions that trigger TDP-43 misfolding, such as heat shock,
p-T153/Y155 is associated with a soluble conformation of the
protein. However, at this time, we cannot exclude the possibility that increased TDP-43 aggregation leads to structures that
make the Thr-153/Tyr-155 inaccessible to phosphorylation.
Next, we asked whether increased TDP-43 phosphorylation
during HSR occurs upon activation of two pathways that mediate TDP-43 clearance: the ubiquitin proteasome system (UPS)
and macroautophagy (autophagy) (28 –30). Cells treated with
the UPS inhibitor MG132, which induces the accumulation of
TDP-43 destined for UPS degradation (28), did not show
changes p-T153/Y155 levels (Fig. 4B). Immunofluorescence
analysis showed the accumulation of cytoplasmic aggregates of
total TDP-43 following MG132 treatment (Fig. 4D), as previously shown (29). However, we observed no colocalization of
p-T153/Y155 with these aggregates. We then asked whether
p-T153/Y155 mediates autophagy-associated degradation of
TDP-43. Cells were exposed to conditions that either increase
autophagy (trehalose, serum starvation), or prevent autophagosome-lysosome fusion (thapsigargin). The levels of p-T153/
Y155 were unaffected under these conditions (Fig. 4B). Moreover, we observed no colocalization of p-T153/Y155 with
microtubule-associated protein light chain 3 (LC-3), a marker
of autophagy vesicles (Fig. 4E). These results indicate that phosphorylation at Thr-153/Tyr-155 is not linked to known pathways of TDP-43 clearance.
MARCH 24, 2017 • VOLUME 292 • NUMBER 12

MEK Regulates TDP-43 Phosphorylation at Thr-153/
Tyr-155—The dual specificity mitogen-activated protein/ERK
kinase (MEK) (isoforms 1/2, MAP2K1/2) is a prime candidate
to phosphorylate at Thr-153/Tyr-155 based on prediction analysis of consensus sequence. Amino acid sequence alignment of
the Thr-153/Tyr-155 region with the dual phosphorylation site
of the well established MEK substrates ERK1/2 (extracellular
signal-regulated kinase) is shown in Fig. 5A. The phosphorylation sites show conservation of the TEY motif, which is unique
for MEK substrates compared with dual phosphorylation consensus sequences of other kinases in the MAPK family. The
glutamic acid residue in the motif is critical for efficient ERK1/2
phosphorylation by MEK (31). Heat shock treatment dramatically increased activation and phosphorylation of MEK (Fig.
5B),inagreementwithpreviousresults(32).Thistriggeredphosphorylation and activation of ERK as well as phosphorylation of
a downstream substrate MSK1 (Fig. 5B). We investigated MEK
phosphorylation of TDP-43 by use of specific kinase inhibitors,
PD184352 and PD98059. Inhibitor treatment prior to heat
shock blocked Thr-153/Tyr-155 phosphorylation (Fig. 5C).
However, inhibition of the downstream kinase ERK with
FR180204 did not decrease Thr-153/Tyr-155 phosphorylation
(Fig. 5C). Addition of okadaic acid, which blocks MEK inactivation by inhibiting protein phosphatase PP1/2A, increased
p-T153/Y155 levels under control and heat shock conditions
(Fig. 5D). This effect was blocked by addition of the MEK inhibitor PD184352. Furthermore, overexpression of a constitutively
active mutant of MEK1, GFP-MEK1_DD (S218D/S222D),
robustly increased TDP-43 phosphorylation at Thr-153/Tyr155 in non-treated cells (Fig. 5E). We also observed increased
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 4. p-T153/Y155 is not associated with aggregation, stress granule recruitment, or clearance of TDP-43. A, fractionation of SH-SY5Y cells performed with control, heat shock-treated cells (43 °C for 30 min), and cells allowed to recover at 37 °C for 1 or 2 h (1 hr R, 2 hr R) following heat shock. Immunoblots
of the total lysate (CL), RIPA (R), and urea (U) soluble fractions detecting p-T153/Y155 and total TDP-43. Equal volumes of total lysate and RIPA soluble fraction
were loaded, whereas the urea fraction is 5-fold more concentrated. B, immunoblots of SH-SY5Y cells treated with the UPS inhibitor MG132 (20 M for 5 h), heat
shock (HS: 43 °C for 30 min), trehalose (100 mM for 24 h), thapsigargin (THP: 1 M, 2 h), and serum starvation (24 h). C, fluorescence microscopy of control and
heat shock-treated HeLa cells detecting p-T153/Y155 and a stress granule marker, TIAR. Arrows indicate TIAR-positive stress granules. D, control and MG132treated HeLa cells (20 M,5 h). Arrows indicate TDP-43 cytoplasmic aggregates detected with a phospho-independent antibody. Bars, 10 m. E, control and
trehalose (100 mM, 24 h) treated HeLa cells. Formation of autophagy vesicles (arrow, lower panels) visualized upon transfection with GFP-fused microtubuleassociated protein 1A/1B-light chain 3 (LC3). Bars, 25 m.

Novel TDP-43 Phosphorylation Is Heat Shock-induced via MEK

phosphorylation of a hemagglutinin (HA)-tagged TDP-43
expressed in the presence of the constitutively active MEK
compared with control (supplemental Fig. S6). Collectively,
these findings strongly suggest that TDP-43 is a novel substrate of MEK and that heat shock is not a prerequisite for
Thr-153/Tyr-155 phosphorylation by constitutively active
MEK.
MEK Phosphorylation at Thr-153 and Tyr-155 Reduces
TDP-43 regulation of Splicing—To explore the effect of Thr153/Tyr-155 phosphorylation on TDP-43 function, we used a
reporter of splicing in cells. The well established cystic fibrosis
transmembrane conductance regulator (CFTR) exon 9 minigene reporter (6, 33) was used in combination with a Thr-153/
Tyr-155 phosphomimetic TDP-43 variant (T153E/Y155E).
TDP-43 prevents exon 9 splicing through binding to a GU-rich
sequence upstream of the 3⬘ splice site (Fig. 6A) (34). Direct
binding of TDP-43 to this sequence recruits additional
hnRNPs, in particular hnRNP A2, preventing recognition of the
3⬘ splice site by steric hindrance (6). Under control conditions,
exon 9 showed 26% inclusion and, as expected, siRNAmediated knockdown of TDP-43 greatly increased exon inclusion (supplemental Fig. S7A) (30). Splicing inhibition was reestablished upon expression of siRNA-resistant wild-type
TDP-43 (WTsiRes) (6, 33). The double mutant Phe-147 and
Phe-149 to Leu (F147L/P149L) was used as control in our assays
because of its inability to regulate splicing due to greatly
reduced RNA binding (35, 36). As expected, F147L/F149L
showed ⬃50% loss in activity compared with wild-type (Fig.
6B). We found that the phosphomimetic T153E/Y155E substitutions caused a 30% loss in splicing inhibition compared with
wild-type and T153E/Y155A, where the phosphosites were
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mutated to alanine to prevent phosphorylation (Fig. 6B). Similar assays were carried out to further analyze the effect of
Thr-153/Tyr-155 and MEK regulation on TDP-43 activity.
Fig. 6C shows CFTR exon 9 splicing activity of control and
siRNA-treated cells as a function of MEK_DD expression. The
relative TDP-43 activity shown in Fig. 6C is a measure of CFTR
exon 9 inclusion levels in each condition compared with
WTsiRes cells. In control cells, MEK_DD reduced inhibition of
CFTR exon 9 splicing by ⬃30% and this effect was lost upon
TDP-43 knockdown. These results suggest that MEK_DD phosphorylation of endogenous TDP-43 decreases splicing regulatory activity, as seen with the phosphomimetic mutation (Fig.
6B). Accordingly, the effect of MEK_DD expression on reporter
exon splicing was re-established in the presence of WTsiRes
TDP-43, where MEK_DD reduced splicing regulation by
⬃50%. In contrast, this effect of MEK_DD was significantly
diminished upon expression of the siRes, non-phosphorylatable, T153A/Y155A TDP-43 mutant. Collectively, our observations suggest that MEK phosphorylation at Thr-153/Tyr-155
inhibits the TDP-43-mediated regulation of splicing.
To elucidate whether the reduced splicing regulatory activity
seen with T153E/Y155E may be caused by changes in RNA
binding affinity, we generated recombinant TDP-43 using
a bacterial expression system. We expressed and purified
TDP-43 fused to a His-SUMO tag at the N terminus to improve
yield and protein solubility. Next, we developed a fluorescencebased RNA binding assay to measure the apparent dissociation
constant (Kd(app)) of TDP-43-RNA interactions as an alternative to the electromobility shift assay (EMSA). This new
method was based on our observations that the intrinsic fluorescence of TDP-43 dramatically decreases upon RNA binding
VOLUME 292 • NUMBER 12 • MARCH 24, 2017
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FIGURE 5. TDP-43 is specifically phosphorylated by MEK at Thr-153/Tyr-155. A, human TDP-43 amino acid sequence surrounding Thr-153 and Tyr-155
(underlined) aligned with the human ERK1 activation loop sequence where MEK phosphorylates at Thr-202 and Tyr-204 (underlined). B, immunoblots of heat
shock and control treated HEK-293 and SH-SY5Y cells. The levels of phospho-independent proteins are shown and tubulin was used as loading control. C,
SH-SY5Y cells treated with specific MEK inhibitors PD184352 (10 M) and PD98059 (50 M), and with a specific inhibitor of the downstream kinase ERK
FR180204 (30 M). Cells were exposed to heat shock following 1 h of inhibitor treatment. D, SH-SY5Y cells treated with the protein phosphatase PP1/2A
inhibitor, okadaic acid (0.5 M), combined with the MEK inhibitor PD184352 for 1 h before heat shock. E, p-T153/Y155 levels analyzed upon expression of the
constitutively active GFP-MEK_DD mutant and a GFP control construct in SH-SY5Y cells in the absence of heat shock.

Novel TDP-43 Phosphorylation Is Heat Shock-induced via MEK

(approximately 50%). Using this assay we obtained Kd(app) ⫽
2.3 ⫾ 0.7 nM for wild-type TDP-43 binding to A(GU)6 with a 1:1
stoichiometry (Fig. 7A, Table 1), in close agreement with values
obtained by EMSA (37). As expected, mutations of Phe-147 and
Phe-149 (F147L/P149L), previously shown to make direct contacts with GU repeats (35, 36), showed a great reduction in
binding affinity (Table 1). We investigated the contribution of
tryptophan residues to the changes in TDP-43 intrinsic fluorescence associated with RNA binding to further validate our
assays. Removal of the C-terminal (⌬C) or both N- and C-terminal domains (fragment 102–269) did not significantly alter
affinity or decrease the change in fluorescence compared with
full-length TDP-43 (Table 1). These results indicate that Trp
residues in the N and C terminus did not contribute to the
fluorescence change linked to RNA binding. Moreover, they are
in agreement with previous work showing that the carboxyland amino-terminal domains of TDP-43 do not contribute to
RNA binding (35). We then substituted the remaining tryptophans at positions 113 and 172, found in RRM1. Substitution of
MARCH 24, 2017 • VOLUME 292 • NUMBER 12

FIGURE 7. Fluorescence-based assay to measure TDP-43 RNA binding
affinity for GU-repeats. A, intrinsic fluorescence (F) of recombinant TDP-43
upon titration of A(UG)6 RNA normalized by the fluorescence in the absence
of RNA (F0). Shown are F/F0 values at four different TDP-43 concentrations and
data were analyzed according to Equations 1 and 2 under “Experimental Procedures.” The best fit values for the apparent equilibrium dissociation constant, Kd(app), are shown in Table 1. B, schematic representation of full-length
TDP-43 highlighting Trp-113 and Trp-172 in RRM1. Lower panel shows the
surface and ribbon representation of the 102–269 fragment bound to GU-rich
RNA (36). Tryptophan residues in RRM1 are highlighted in magenta.

TABLE 1
Binding affinities of wild-type and mutant TDP-43
The apparent equilibrium dissociation constant Kd(app) measured for recombinant
TDP-43 binding to A(GU)6 RNA.
Kd(app)
nM

Wild-type
⌬C (aa 1–261)
RRM1–2 (aa 102–269)
RRM1–2 W113A
RRM1–2 W113F
RRM1–2 W172F
RRM1–2 W172A
F147/149L
T153A/Y155A
T153E/Y155E
a

2.3 ⫾ 0.5
2.8 ⫾ 0.6
2.2 ⫾ 0.5
NDa
6.0 ⫾ 0.6
2.0 ⫾ 0.4
5.0 ⫾ 0.6
NDa
3.1 ⫾ 0.6
10 ⫾ 3

ND, not determined.

Trp-113 to Ala (W113A) results in the loss of the fluorescence
signal change as a function of RNA, whereas W113F reduced
the fluorescence change by 50%, but had a modest effect on the
Kd(app) (Table 1). Mutations of Trp-172 to either phenylalanine
or alanine did not affect binding affinity or fluorescence change
in our assays (Table 1). Our findings strongly suggest that
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FIGURE 6. Phosphomimetic substitutions at Thr-153/Tyr-155 modulate
TDP-43 activity. A, schematic representation of the CFTR exon 9 mini-gene
cellular reporter of TDP-43 activity. Exons and intron regions are represented
as boxes and lines, respectively. TDP-43 binding to UG repeats (UG13) near the
3⬘ splice site inhibits exon 9 inclusion. The two major products of splicing are
shown to the right. B, RNAi-resistant (siRes) TDP-43 mutants were expressed
in siRNA-treated HeLa cells. Relative TDP-43 activity was calculated comparing wild-type siRes. The effect of the RNA binding-deficient mutant, F147L/
F149L, was used as control. Error bars, S.D., n ⬎ 5. C, constitutively active
MEK_DD, or control GFP vector, expressed in siRNA or control treated cells.
Reporter activity was analyzed relative to siRes wild-type (WTsiR). Values represent the averages of independent transfection experiments. Error bars, S.D.,
n ⱖ 4.

Novel TDP-43 Phosphorylation Is Heat Shock-induced via MEK
changes surrounding the Trp-113 region are principally
responsible for the observed decrease in intrinsic fluorescence
upon RNA binding. Trp-113 makes sequence-specific contacts
with GU-rich RNA and substitutions of this residue reduce
binding affinity (36, 37). These interactions, according to our
data, result in dramatic changes in intrinsic fluorescence that
may be exploited to accurately measure RNA binding affinity.
Analysis of T153E/Y155E using the fluorescence-based assay
showed a 5-fold decrease in A(GU)6 binding affinity in the presence of the phosphomimetic substitutions compared with wildtype, whereas the corresponding alanine mutations did not
affect binding (Table 1). These results are consistent with the
reduced splicing regulatory function seen in the presence of the
phosphomimetic substitutions and strongly suggest that phosphorylation modulates TDP-43 activity.
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Experimental Procedures
Materials—All reagents are from Sigma unless otherwise
specified. The human cell lines: neuroblastoma SH-SY5Y, epithelial HeLa, and embryonic kidney HEK-293 cells were purchased from ATCC.
Plasmid Construction—FLAG-tagged wild-type TDP-43,
siRNA-resistant construct for mammalian expression was previously described (7). This served as template for site-directed
mutagenesis using the QuikChange site-directed mutagenesis
kit (Agilent Technologies) to generate TDP-43 mutants for
mammalian expression. MEK1_DD-GFP (S218D/S222D) was
generated by site-directed mutagenesis using the wild-type
MEK1-GFP construct (Addgene, 14746) as template. pEGFPVOLUME 292 • NUMBER 12 • MARCH 24, 2017
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Discussion
TDP-43 regulates hundreds of genes through different RNA
processing mechanisms, in particular through the regulation of
splicing (18, 19, 22). TDP-43 cellular localization is highly
dynamic and defects in nuclear import are linked to aggregation
and neurotoxicity (9, 38, 39). How these various TDP-43 functions are controlled in cells is largely unknown. Previously
determined TDP-43 phosphorylation sites at Ser-403/404 and
Ser-409/410 are poorly associated with the control of TDP-43
function and are mostly markers of pathological aggregates (25,
26). Here we report dual phosphorylation of TDP-43 at Thr153/Tyr-155 and provide strong evidence that it is specifically
controlled by the MAPK/ERK kinase MEK. This phosphorylation is dramatically up-regulated by the HSR in human cells.
The increase in p-T153/Y155 is not associated with greater
aggregation or protein clearance under the conditions tested.
We find, instead, that p-T153/Y155 remains soluble under conditions that promote TDP-43 misfolding. In support of a functional role of p-T153/Y155, our results show that increased
MEK activity significantly alters TDP-43-mediated control of
exon splicing in cells. Our observations suggest that the effect of
MEK is mediated by phosphorylation at Thr-153/Tyr-155. The
decrease in TDP-43 activity may be at least partly explained by
a reduction in RNA binding as we find that T153E/Y155E binds
GU-rich RNA with 5-fold lower affinity. Future studies should
determine whether phosphorylation changes RNA sequence
specificity, or whether it affects protein interactions required
for TDP-43 regulation of splicing, such as binding to hnRNP A2
(6).
The dramatic up-regulation of TDP-43 phosphorylation by
heat shock, along with recent findings on the reduction of
TDP-43 aggregation upon heat shock factor 1 (HSF1) activation
(40, 41), point to a previously unappreciated role of HSR in
TDP-43 homeostasis and posttranslational regulation. In addition to hyperthermic stress, HSR is activated by other types of
insults that compromise protein homeostasis (42, 43), and
defects in this response are commonly found in human disease
including neurodegeneration. Therapies targeting HSR pathways, such as those showing promising effects in ALS (44),
may be designed to specifically target TDP-43. We posit that
p-T153/Y155 might mediate interactions with chaperones/
heat shock proteins that prevent TDP-43 misfolding and aggre-

gation, such as DNAJB2a and Hsp70 (40). Alternatively, it may
be associated with an HSR-mediated clearance pathway, different from UPS and autophagy, which prevents aggregate accumulation. We also propose the alternative, tantalizing scenario
that TDP-43 might regulate the expression of the HSR target
genes whose levels are controlled by alternative splicing during
the proteotoxic stress response (45). Based on our findings, this
HSR-specific function of TDP-43 may be controlled by phosphorylation at Thr-153/Tyr-155.
MEK is activated upon heat shock and was recently shown to
maintain protein homeostasis, at least in part, by phosphorylating and activating HSF1 (32). Previously, the only other recognized MEK substrate was ERK. Now, we provide evidence that
TDP-43 is a novel MEK substrate in the presence and absence
of heat shock. MEK may not be the only kinase to phosphorylate TDP-43 at Thr-153/Tyr-155, however, we observed no significant reduction of HSR-induced p-T153/Y155 levels upon
specific inhibition of MAPK-related dual specificity kinases,
namely JNK and p38 kinase (supplemental Fig. S8). Our evidence suggests that cellular processes associated with active
MEK, such as proliferation and differentiation, may also induce
p-T153/Y155 and regulate TDP-43 function. Based on our findings that p-T153/Y155 is associated with TDP-43 solubility in
conditions that trigger protein misfolding, future work should
determine whether MEK activation prevents TDP-43 aggregation and blocks TDP-43-associated neurotoxicity.
Our findings showing the specific localization of phosphorylated TDP-43 suggest that nucleolar TDP-43 recruitment is
regulated by phosphorylation and may provide new insight into
a previously unrecognized role of TDP-43 in cellular function linked to nucleolar RNA processing. In the C9ORF72
hexanucleotide repeat expansion, which is the most common
cause of familial ALS and FTD (46, 47), the nucleolar compartment is disrupted by the generation of arginine-rich (GR and
PR) dipeptide repeats (48 –50). GR and PR are toxic, accumulate in nucleoli, and bind to proteins containing low complexity
sequence domains including TDP-43 (51, 52). These findings
strongly suggest that one of the principal pathogenic mechanisms in ALS/FTD is abnormal nucleolar function. Future
experiments will determine TDP-43 function, particularly the
role of p-T513/Y155 in nucleolar-specific RNA processing, and
the effect of Arg-rich dipeptide repeats on this function. This
may elucidate a convergent process resulting from TDP-43 and
C9ORF72-associated dysfunction in ALS/FTD pathogenesis.
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compare the levels of exon inclusion/exclusion. PCR products
were quantified with ImageJ.
Phosphatase Treatment—Cell lysates containing ⬃30 g of
total protein were incubated with 400 units of -protein phosphatase (New England Biolabs) for 1 h at 37 °C according to the
manufacturer’s instructions.
Peptide Competition—p-T153/Y155 antibody was incubated
with a peptide corresponding to amino acids 148 –161 of
TDP-43 phosphorylated at positions Thr-153 and/or Tyr-155.
Non-phosphorylated peptide was used as a control. Prior to
immunoblotting or immunofluorescence 1 mg/ml of p-T153/
Y155-TDP-43 antibody was incubated with 0.02 g/ml (low)
and 1 g/ml (high) peptide for 1 h at 25 °C.
Immunoblotting and Immunofluorescence Microscopy—Cell
pellets were resuspended in lysis buffer (0.25 M NaCl, 15 mM
Hepes, pH 7.5, 0.5% Nonidet P-40, 10% glycerol, 1⫻ protease
inhibitor mixture, 1⫻ Phostop Phosphatase inhibitor mixture
(Roche Applied Science)). Approximately 30 g of total protein
were loaded for immunoblot analyses, unless otherwise specified. Samples were measured by Bradford assays. Proteins were
separated by SDS-PAGE and transferred to nitrocellulose (0.22
m, GE Healthcare). Membranes were blocked with 5%
BSA/TBS-Tween and immunodetection was carried out by
enhanced chemiluminescence (ECL, Pierce, ThermoFisher Scientific). Antibodies against phospho-independent TDP-43
were used to compare p-T153/Y155 levels with total TDP-43.
Either tubulin or GAPDH was used as the loading control.
Indirect immunofluorescence was carried out as previously
described (17). Cells were observed on a Leica DM5000B
microscope equipped with the DFC350FX digital camera (Leica
Microsystems Inc.). A ⫻63/1.4 oil immersion objective was
used for confocal microscopy studies on a TCS SP5 microscope
(Leica) using the LAS AF software.
Immunohistochemistry—We studied FTLD cases with
TDP-43 pathology and age-matched controls from the Northwestern Neuropathology Core Tissue Bank (NADC AG13854).
Frontal cortex and dentate gyrus sections were immunostained
according to previously described protocols (55) with p-T153/
Y155-TDP-43. pS409/410 (Cosmo Bio USA) antibody was used
as control.
Expression and Purification of Recombinant TDP-43—
Recombinant TDP-43 was expressed in BL21(DE3) Escherichia
coli cells from the SUMO-TDP43 plasmid. Induction was carried out with 0.3 mM isopropyl ␤-D-thiogalactopyranoside and
cells were grown at 25 °C for 4 h. Cell pellets were resuspended
in lysis buffer (500 mM NaCl, 50 mM Tris, pH 8.0, 1 mM Tris(2carboxyethyl)phosphine, 10% sucrose, 10% glycerol, 5 mM
CHAPS, 0.1% sodium deoxycholate, EDTA-free protease
inhibitor mixture, 2.5 g/ml of lysozyme, 10 g/ml of DNase I).
Lysates were centrifuged for 20 min at 20,000 ⫻ g at 4 °C following sonication on ice. Protein was isolated on nickelnitrilotriacetic acid resin (McLab) by affinity chromatography
(AKTA-Start, GE Healthcare). The column was washed with
Buffer A: 500 mM NaCl, 50 mM Tris, pH 8.0, 10% sucrose, 10%
glycerol, 50 mM imidazole. Recombinant TDP-43 was eluted
with Buffer A and 300 mM imidazole. The SUMO tag was
removed with Ulp1 protease at a 1:1,000 (w/w) ratio as
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LC3 vector was purchased from Addgene (24920). Constructs
for bacterial TDP-43 expression (SUMO-TDP43) were made
by cloning TDP-43 in pET-28b/His-SUMO (53) using pQTDPBam_FW and SacTDPend_RV. This construct was the template to generate TDP-43 mutants for bacterial expression
through site-directed mutagenesis as above. pQTDPBam_FW
and Sac_269_RV; Bam_102_FW and Sac_269_RV were used to
clone ⌬C-TDP-43 and fragment 102–269, respectively. Oligonucleotides used for mutagenesis and cloning are described in
supplemental Table S1. The pLKO vector for TDP-43 downregulation was generated by ligation of shT2_FW and shT2_RV
annealing product into pLKO.1-puro vector digested with AgeI
and EcoRI.
Cell Culture, Fractionation, and Splicing Assays—Human
cell lines were grown in growth media, Dulbecco’s modified
Eagle’s medium, 4,500 mg/liter of glucose, L-glutamine, and
sodium bicarbonate, and supplemented with filtered fetal
bovine serum at 10%. For the soluble and insoluble fractions cell
pellets were resuspended in RIPA buffer (150 mM NaCl, 50 mM
Tris, pH 8.0, 1% Nonidet P-40, 5 mM EDTA, 0.5% sodium
deoxycholate, 0.1% SDS, 1⫻ protease inhibitor mixture, 1⫻
Phostop Phosphatase inhibitor mixture (Roche Applied Science)). Lysates were sonicated using a Bioruptor Pico (Diagenode) using 10, 30-s on/30-s off, cycles at 4 °C and centrifuged
at 40,000 ⫻ g for 30 min at 4 °C. The pellet was rinsed with RIPA
buffer and the final pellet was resuspended in urea buffer (7 M
urea, 2 M thiourea, 4% CHAPS, and 30 mM Tris, pH 8.5). Stable
HEK-293 cells expressing HA-tagged TDP-43 under tetracycline induction (7) were used for immunoprecipitation experiments as previously described (54). RNAi-mediated down-regulation of TDP-43 was carried out as previously described (33)
and siCONTROL Nontargetting siRNA#1 (Dharmacon) was
used as control. shRNA-mediated down-regulation of TDP-43
was carried out by generating lentiviral particles in HEK-293T
cells using a pLKO vector system (pCMV8.2⌬R, pCMVVSV-G, generous gifts of Susana Gonzalo’s lab, St. Louis University). shRNA luciferase lentiviral particles were generated
for control transduction. HEK-293T cells were transfected
with Lipofectamine 2000 (Life Technologies) in Opti-MEM
Reduced Serum Media (Life Technologies) according to manufacturer’s protocols. After 6 h, media was replaced with
growth media and cells were incubated at 37 °C, 5% CO2 for 48 h.
After 48 h, the lentivirus-containing media was collected and filter
sterilized with a 0.45-m filter. HeLa cells were transduced with
control and TDP-43-shRNA lentiviral particles with Polybrene
transfection reagent. TDP-43 knockdown clones were generated
by puromycin selection (1 g/ml) 48 h after transduction. TDP-43
down-regulation was confirmed by immunoblotting.
Splicing assays were carried out in HeLa cells transiently
transfected with Lipofectamine 2000 and Oligofectamine in the
case of siRNA (Life Technologies) according to the manufacturer’s protocols. Assays were performed using the CFTR
reporter mini-gene as previously described (6, 33). Briefly, following two transfections with control or siRNA TDP-43 (0.1
nmol) in a 6-well format, cells were co-transfected with FLAGTDP43 siRNA-resistant constructs of wild-type or mutant
TDP-43 and the CFTR reporter (0.3 g each) (17). RNA was
extracted after 24 h and RT-PCR analysis was performed to
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described (53). Ulp1 was generously provided by Sergey
Korolev’s group. All steps were carried out at 4 °C.
Fluorescence Titration RNA Binding Assays—TDP-43 intrinsic fluorescence was measured upon titration with increasing
concentrations of A(GU)6 RNA on a Fluoromax-4 spectrofluorometer (Horiba Scientific). Fluorescence readings were performed in a 1-ml cuvette at four different recombinant TDP-43
concentrations in the range of 10 –100 nM in the presence of
200 mM NaCl, 20 mM Tris, pH 8.0, 0.1% PEG-8000, 2% glycerol,
at 25 °C. Protein was excited at 280 nm (slits 5/10, exposure
time of 0.02 s), and emission was recorded at 340 nm. We
observed no significant photobleaching under these conditions.
Data were analyzed with Origin (version 8.1, OriginLab)
according to Equation 1,
F ⫽ F 0 ⫹ ⌬F max

(Eq. 1)

⫽

K d共app兲 ⫹ NTt ⫹ Rt ⫺ 冑共Kd共app兲 ⫹ NTt ⫹ Rt兲2 ⫺ 4NTtRt
2NTt

(Eq. 2)

Equation 2 describes the fractional saturation in terms of the
apparent equilibrium dissociation constant Kd(app), the total
concentration of TDP-43 (Tt), total RNA concentration (Rt),
and TDP-43:RNA binding stoichiometry, N. Four TDP-43RNA binding curves were analyzed simultaneously to obtain
Kd(app) and N.
Antibodies—Immunoblots and indirect immunofluorescence were performed with: rabbit polyclonal and mouse
monoclonal anti-TDP-43 (ProteinTech 10782-2-AP, Abcam,
ab109535), anti-TIAR (BD Biosciences, 610352), anti-fibrillarin
(Abcam, ab4566), mouse anti-tubulin (Andres Muro, Trieste,
Italy), anti-GAPDH (Abcam, ab181602), anti-MEK (Abcam,
ab178876), anti-phospho-MEK1/2 (Cell Signaling, number
9154), anti-ERK1/2 (Cell Signaling, number 4695), anti-phospho-ERK1/2 (Cell Signaling, number 4370), anti-MSK1 (Cell
Signaling, number 3489), and anti-phospho-MSK1 (Cell Signaling, number 9595). The rabbit polyclonal antibodies recognizing p-T153/Y155 and p-Y155-TDP-43 were produced by
21st Century Biochemicals, MA. Peptide including TDP-43
amino acids 148 –161 phosphorylated at either Thr-153/Tyr155 or Tyr-155 served as epitope for antibody production. Antibody specificity was enhanced by affinity purification to select
for binding to phosphorylated Thr-153/Tyr-155 or Tyr-155,
but not the corresponding non-phosphorylated peptides.
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R. L. F., E. H. B., and Y. M. A. designed the research, performed the
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where F is fluorescence, F0 is F in the absence of RNA, ⌬Fmax is
the total change in F at saturation.
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